Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence

mSphere(2022)10.1128/msphere.00257-22Source: DataRank Database

Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence is a research paper published in mSphere (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.10)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Keri N. Althoff ORCID,David J. Schlueter,Hoda Anton‐Culver ORCID,Qingxia Chen ORCID,Shawn Garbett ORCID

Live enrichment

PubMed:36173112 PMC:PMC9599436 OpenAlex:https://openalex.org/W4297965131

HHS | NIH | National Cancer Institute

Grant: HHSN261201500003I

HHS | NIH | National Cancer Institute

Grant: 75N91019D00024

HHS | NIH | NIH Office of the Director

Grant: OT2OD026552

HHS | NIH | NIH Office of the Director

Grant: 1OT2OD026553

HHS | NIH | NIH Office of the Director

Grant: 3OT2OD026553-01S3

HHS | NIH | NIH Clinical Center

Grant: U2OD023196

HHS | NIH | NIH Clinical Center

Grant: 5 U2C OD023196-03

HHS | NIH | NIH Clinical Center

Grant: 5U2COD023196-04

NIH HHS

Grant: OT2 OD026553

NIH HHS

Grant: U2C OD023196

FWCI

0.10

Citation Percentile

0.4%

Citation Trend

2023

goldLicense: cc-by

journalhttps://doi.org/10.1128/msphere.00257-22

publisherhttps://doi.org/10.1128/msphere.00257-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/msphere.00257-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36173112

repositoryhttps://doaj.org/article/7930847087474e8a85c0a61186606340

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research StudiesHumansSARS-CoV-2COVID-19PrevalenceSeroepidemiologic StudiesSensitivity and SpecificityPopulation HealthAntibodies, ViralImmunoglobulin G

MeSH Terms

Population HealthCOVID-19SARS-CoV-2Antibodies, ViralHumansImmunoglobulin GSensitivity and SpecificityPrevalenceSeroepidemiologic Studies

Keywords

ConcordanceMedicineConfidence intervalSeroprevalenceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Roche DiagnosticsAntibody2019-20 coronavirus outbreakImmunoassayInternal medicineVirologyImmunologySerologyOutbreakDiseaseSpike proteinNucleocapsid proteinIgG antibodiesLow PrevalenceSars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being